✦ LIBER ✦

Other: Opioid-induced bowel dysfunction: a survey of prevalence and risk factors in chronic non-malignant pain patients

✍ Scribed by K. Fakata; A. Tuteja; A. Lipman; M. Ho

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Opioid-induced bowel disorders and narco

✍ A. K. Tuteja; J. Biskupiak; G. J. Stoddard; A. G. Lipman 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 512 KB

Subcutaneous methylnaltrexone improves b

✍ M. Duerden; A. Weil; D. Yu; S. Schulman; E. Tzanis; A. Manley; H. Zhang; B. Rand 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 36 KB

The Prevalence, Severity, and Impact of

✍ Timothy J. Bell; Sunil J. Panchal; Christine Miaskowski; Susan C. Bolge; Tsveta 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 260 KB

Subcutaneous methylnaltrexone for the tr

✍ R. Blonsky; E. Michna; S. Schulman; E. Tzanis; A. Manley; H. Zhang; B. Randazzo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 37 KB

878 PREVALENCE OF ANXIETY AND DEPRESSION

✍ X. Santiveri; M.D. Ferrer; A. Ruiz; R. Lopez; N. Pares; F. Escolano 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Subcutaneous methylnaltrexone does not e

✍ A. Weil; M. Duerden; S. Schulman; E. Tzanis; D. Yu; A. Manley; H. Zhang; B. Rand 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 36 KB